Skip to main content
. Author manuscript; available in PMC: 2022 Feb 18.
Published in final edited form as: Vaccine. 2015 Feb 21;33(17):2079–2085. doi: 10.1016/j.vaccine.2015.02.027

Table 5.

Results of sensitivity analyses considering age dependent vaccine effectiveness.

Item Valuea and 90% confidence interval
Averted burden per year (total cases), including 1514 (396–4041)
 Averted cases among individuals <5 years oldb 40 (16–101)
 Averted cases among individuals ≥5 years old & <15 years old 588 (159–1572)
 Intestinal perforations 76 (20–202)
 Deaths 34 (8–92)
DALYs averted over duration 3316 (814–8953)
No vaccine dose donation
 Net costs per DALY averted 693 (32–2057)
 Net costs per case averted 489 (23–1424)
Vaccine dose donation
 Program Costs 103 (93–112)
 Net costs per DALY averted CS (CS–19)
 Net costs per case averted CS (CS–14)

CS: Cost Saving

a

All costs in 2014 US$.

b

The vaccine was considered to avert cases only for those >2 years old.